2-Cyano-1-ethyl-3-[4-(1H-imidazol-4-yl)butyl]guanidine

ID: ALA1077756

PubChem CID: 44482031

Max Phase: Preclinical

Molecular Formula: C11H18N6

Molecular Weight: 234.31

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCN/C(=N\C#N)NCCCCc1c[nH]cn1

Standard InChI:  InChI=1S/C11H18N6/c1-2-14-11(16-8-12)15-6-4-3-5-10-7-13-9-17-10/h7,9H,2-6H2,1H3,(H,13,17)(H2,14,15,16)

Standard InChI Key:  FJZUWLCPOQUBLF-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 17 17  0  0  0  0  0  0  0  0999 V2000
    5.5748  -20.7267    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3770  -20.5338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4433  -19.7114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6787  -19.3947    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1459  -20.0234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1471  -19.2810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8718  -19.6754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5756  -19.2451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3003  -19.6394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0041  -19.2091    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.7080  -18.7787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4326  -19.1731    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.6872  -17.9540    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.3911  -17.5236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1000  -17.1042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.4534  -19.9979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1780  -20.3922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  3  4  1  0
  8  9  1  0
  4  5  2  0
  9 10  1  0
  5  1  1  0
 10 11  1  0
  1  2  1  0
 11 12  1  0
  3  6  1  0
 11 13  2  0
 13 14  1  0
  6  7  1  0
 14 15  3  0
  2  3  2  0
 12 16  1  0
  7  8  1  0
 16 17  1  0
M  END

Alternative Forms

Associated Targets(Human)

HRH4 Tchem Histamine H4 receptor (3997 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH1 Tclin Histamine H1 receptor (7573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH2 Tclin Histamine H2 receptor (5428 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH3 Tclin Histamine H3 receptor (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 234.31Molecular Weight (Monoisotopic): 234.1593AlogP: 0.77#Rotatable Bonds: 6
Polar Surface Area: 88.89Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.74CX LogP: 0.54CX LogD: 0.46
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.29Np Likeness Score: -0.92

References

1. Igel P, Geyer R, Strasser A, Dove S, Seifert R, Buschauer A..  (2009)  Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,  52  (20): [PMID:19791743] [10.1021/jm900526h]

Source